vs
Side-by-side financial comparison of SOCIETY PASS INCORPORATED. (SOPA) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.4M, roughly 1.6× SOCIETY PASS INCORPORATED.). Instil Bio, Inc. runs the higher net margin — -365.3% vs -370.8%, a 5.5% gap on every dollar of revenue. On growth, SOCIETY PASS INCORPORATED. posted the faster year-over-year revenue change (-17.6% vs -19.2%).
The Wilderness Society is an Australian, community-based, not-for-profit non-governmental environmental advocacy organisation.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
SOPA vs TIL — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $2.2M |
| Net Profit | $-5.1M | $-8.2M |
| Gross Margin | 64.3% | — |
| Operating Margin | -379.9% | -426.3% |
| Net Margin | -370.8% | -365.3% |
| Revenue YoY | -17.6% | -19.2% |
| Net Profit YoY | -271.5% | 31.1% |
| EPS (diluted) | $-0.89 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.2M | ||
| Q3 25 | $1.4M | $2.2M | ||
| Q2 25 | $2.5M | $2.2M | ||
| Q1 25 | $1.5M | $2.2M | ||
| Q4 24 | $1.9M | $2.8M | ||
| Q3 24 | $1.7M | $1.5M | ||
| Q2 24 | $1.7M | $0 | ||
| Q1 24 | $1.8M | $0 |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | $-5.1M | $-13.6M | ||
| Q2 25 | $479.0K | $-21.4M | ||
| Q1 25 | $-1.8M | $-28.2M | ||
| Q4 24 | $-4.1M | $-11.9M | ||
| Q3 24 | $-1.4M | $-23.0M | ||
| Q2 24 | $-1.9M | $-14.9M | ||
| Q1 24 | $-2.8M | $-24.3M |
| Q4 25 | — | — | ||
| Q3 25 | 64.3% | — | ||
| Q2 25 | 56.5% | — | ||
| Q1 25 | 31.6% | — | ||
| Q4 24 | 28.9% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 27.1% | — | ||
| Q1 24 | 26.7% | — |
| Q4 25 | — | -426.3% | ||
| Q3 25 | -379.9% | -670.0% | ||
| Q2 25 | -6.1% | -1045.5% | ||
| Q1 25 | -126.6% | -1363.2% | ||
| Q4 24 | -165.6% | -426.1% | ||
| Q3 24 | -70.1% | -1582.8% | ||
| Q2 24 | -126.0% | — | ||
| Q1 24 | -156.6% | — |
| Q4 25 | — | -365.3% | ||
| Q3 25 | -370.8% | -606.0% | ||
| Q2 25 | 19.1% | -954.2% | ||
| Q1 25 | -124.9% | -1257.8% | ||
| Q4 24 | -217.5% | -428.8% | ||
| Q3 24 | -82.2% | -1541.9% | ||
| Q2 24 | -113.3% | — | ||
| Q1 24 | -153.8% | — |
| Q4 25 | — | $-1.13 | ||
| Q3 25 | $-0.89 | $-2.01 | ||
| Q2 25 | $0.10 | $-3.24 | ||
| Q1 25 | $-0.44 | $-4.32 | ||
| Q4 24 | $-1.03 | $-1.82 | ||
| Q3 24 | $-0.48 | $-3.54 | ||
| Q2 24 | $-0.73 | $-2.29 | ||
| Q1 24 | $-1.21 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.6M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.9M | $113.9M |
| Total Assets | $32.9M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.6M | ||
| Q3 25 | $6.6M | $5.8M | ||
| Q2 25 | $8.2M | $7.7M | ||
| Q1 25 | $7.1M | $15.4M | ||
| Q4 24 | $7.6M | $8.8M | ||
| Q3 24 | $4.2M | $6.7M | ||
| Q2 24 | $833.9K | $6.8M | ||
| Q1 24 | $1.6M | $5.5M |
| Q4 25 | — | $113.9M | ||
| Q3 25 | $13.9M | $120.4M | ||
| Q2 25 | $2.4M | $131.7M | ||
| Q1 25 | $-663.0K | $144.9M | ||
| Q4 24 | $-2.1M | $169.4M | ||
| Q3 24 | $862.6K | $176.3M | ||
| Q2 24 | $2.4M | $195.0M | ||
| Q1 24 | $3.5M | $205.8M |
| Q4 25 | — | $203.5M | ||
| Q3 25 | $32.9M | $211.8M | ||
| Q2 25 | $29.2M | $231.0M | ||
| Q1 25 | $22.9M | $237.4M | ||
| Q4 24 | $21.3M | $263.6M | ||
| Q3 24 | $17.0M | $272.6M | ||
| Q2 24 | $13.0M | $294.3M | ||
| Q1 24 | $13.3M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.7M | $-7.1M |
| Free Cash FlowOCF − Capex | $-16.7M | — |
| FCF MarginFCF / Revenue | -1211.0% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-7.1M | ||
| Q3 25 | $-16.7M | $-10.6M | ||
| Q2 25 | $-1.8M | $-14.8M | ||
| Q1 25 | $-4.0M | $-4.2M | ||
| Q4 24 | $3.7M | $-10.6M | ||
| Q3 24 | $2.0M | $-20.1M | ||
| Q2 24 | $-864.6K | $-10.6M | ||
| Q1 24 | $-2.4M | $-14.4M |
| Q4 25 | — | — | ||
| Q3 25 | $-16.7M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -1211.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -3.70× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
